Related Experiment Video
Updated: Mar 7, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Neuronal death signaling pathways triggered by mutant LRRK2
1Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece hrideout@bioacademy.gr.
Abstract:
Autosomal dominantly inherited mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease. While considerable progress has been made in understanding its function and the many different cellular activities in which it participates, a clear understanding of the mechanism(s) of the induction of neuronal death by mutant forms of LRRK2 remains elusive. Although several in vivo models have documented the progressive loss of dopaminergic neurons of the substantia nigra, more complete interrogations of the modality of neuronal death have been gained from cellular models. Overexpression of mutant LRRK2 in neuronal-like cell lines or in primary neurons induces an apoptotic type of cell death involving components of the extrinsic as well as intrinsic death pathways. While informative, these studies are limited by their reliance upon isolated neuronal cells; and the pathways triggered by mutant LRRK2 in neurons may be further refined or modulated by extracellular signals. Nevertheless, the identification of specific cell death-associated signaling events set in motion by the dominant action of mutant LRRK2, the loss of an inhibitory function of wild-type LRRK2, or a combination of the two, expands the landscape of potential therapeutic targets for future intervention in the clinic.
Insights
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause Parkinson's disease. Mutant LRRK2 triggers apoptotic neuronal death, offering potential therapeutic targets for this neurodegenerative disorder.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease (PD).
- Understanding the precise mechanisms by which mutant LRRK2 induces neuronal death is crucial for developing effective PD therapies.
- While in vivo models show dopaminergic neuron loss, cellular models offer detailed insights into cell death pathways.
Purpose of the Study:
- To elucidate the cell death mechanisms induced by mutant LRRK2.
- To identify specific signaling events involved in mutant LRRK2-mediated neuronal apoptosis.
- To explore potential therapeutic targets based on these identified pathways.
Main Methods:
- Overexpression of mutant LRRK2 in neuronal-like cell lines and primary neurons.
- Analysis of apoptotic cell death pathways, including extrinsic and intrinsic components.
- Investigation of signaling events triggered by mutant LRRK2.
Main Results:
- Overexpression of mutant LRRK2 induces apoptosis in neuronal models.
- Both extrinsic and intrinsic apoptotic pathways are implicated in mutant LRRK2-mediated cell death.
- Specific cell death-associated signaling events are identified.
Conclusions:
- Mutant LRRK2 directly triggers apoptotic neuronal death through well-defined cellular pathways.
- The identified signaling events represent potential therapeutic targets for Parkinson's disease.
- Further research may refine understanding of these pathways in a more complex cellular environment.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
Neural Regulation
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Intrinsic Apoptotic Pathway

